2-bromo-N-[3-(methoxymethyl)-1-(2-phenylethyl)pyrazol-4-yl]acetamide

C15H18BrN3O2 — CID 67198226

IUPAC2-bromo-N-[3-(methoxymethyl)-1-(2-phenylethyl)pyrazol-4-yl]acetamide
SMILESCOCc1nn(CCc2ccccc2)cc1NC(=O)CBr
InChIInChI=1S/C15H18BrN3O2/c1-21-11-14-13(17-15(20)9-16)10-19(18-14)8-7-12-5-3-2-4-6-12/h2-6,10H,7-9,11H2,1H3,(H,17,20)
InChIKeyOVCQBSUTVJUSCY-UHFFFAOYSA-N
MW352.23 g/mol
LogP2.61
Rot. Bonds7

About 2-bromo-N-[3-(methoxymethyl)-1-(2-phenylethyl)pyrazol-4-yl]acetamide

2-bromo-N-[3-(methoxymethyl)-1-(2-phenylethyl)pyrazol-4-yl]acetamide (PubChem CID 67198226) has the molecular formula C15H18BrN3O2 and a molecular weight of 352.23 g/mol. Its IUPAC name is 2-bromo-N-[3-(methoxymethyl)-1-(2-phenylethyl)pyrazol-4-yl]acetamide.

Molecular Properties

Compound Name2-bromo-N-[3-(methoxymethyl)-1-(2-phenylethyl)pyrazol-4-yl]acetamide
PubChem CID67198226
Molecular FormulaC15H18BrN3O2
Molecular Weight352.23 g/mol
Exact Mass351.06
IUPAC Name2-bromo-N-[3-(methoxymethyl)-1-(2-phenylethyl)pyrazol-4-yl]acetamide
SMILESCOCc1nn(CCc2ccccc2)cc1NC(=O)CBr
InChIInChI=1S/C15H18BrN3O2/c1-21-11-14-13(17-15(20)9-16)10-19(18-14)8-7-12-5-3-2-4-6-12/h2-6,10H,7-9,11H2,1H3,(H,17,20)
InChIKeyOVCQBSUTVJUSCY-UHFFFAOYSA-N
XLogP2.61
TPSA56.15 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds7
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500352.23
LogP ≤ 52.61
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Analyze 2-bromo-N-[3-(methoxymethyl)-1-(2-phenylethyl)pyrazol-4-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[3-formyl-1-(2-phenylethyl)pyrazol-4-yl]-3-phenylpropanamide
CID 88945714
4-[[2-(4-bromophenyl)sulfanylacetyl]amino]-1-(2-phenylethyl)pyrazole-3-carboxylic acid
CID 25009726
methyl 4-[(2-bromoacetyl)amino]-1-(1-phenylethyl)pyrazole-3-carboxylate
CID 154156832
4-[[2-(4-fluorophenyl)sulfanylacetyl]amino]-1-(2-phenylethyl)pyrazole-3-carboxylic acid
CID 141201998
1-ethyl-N-phenyl-4-(3-phenylpropanoylamino)pyrazole-3-carboxamide
CID 19404606
2-(4-methoxyphenyl)-N-[1-(2-phenylethyl)pyrazol-4-yl]acetamide
CID 95744739
N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]-4-phenylbutanamide
CID 847079
methyl 4-(2-phenylethyl)piperazine-1-carboxylate
CID 1246166
ethyl 4-amino-1-(2-phenylethyl)pyrazole-3-carboxylate
CID 107345048
1-[[4-(hydroxymethyl)phenyl]methyl]-3-(methoxymethyl)pyrazole-4-carboxylic acid
CID 142600883
2-(2-phenylethyl)indazole-6-carboxylic acid
CID 176884936
3-phenyl-N-[1-(2-phenylethyl)pyrazol-4-yl]propanamide
CID 95744744

Frequently Asked Questions

What is the IUPAC name of 2-bromo-N-[3-(methoxymethyl)-1-(2-phenylethyl)pyrazol-4-yl]acetamide?
The IUPAC name of 2-bromo-N-[3-(methoxymethyl)-1-(2-phenylethyl)pyrazol-4-yl]acetamide (CID 67198226) is 2-bromo-N-[3-(methoxymethyl)-1-(2-phenylethyl)pyrazol-4-yl]acetamide.
What is the SMILES notation for 2-bromo-N-[3-(methoxymethyl)-1-(2-phenylethyl)pyrazol-4-yl]acetamide?
The canonical SMILES for 2-bromo-N-[3-(methoxymethyl)-1-(2-phenylethyl)pyrazol-4-yl]acetamide is COCc1nn(CCc2ccccc2)cc1NC(=O)CBr.
What is the InChIKey of 2-bromo-N-[3-(methoxymethyl)-1-(2-phenylethyl)pyrazol-4-yl]acetamide?
The InChIKey is OVCQBSUTVJUSCY-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H18BrN3O2/c1-21-11-14-13(17-15(20)9-16)10-19(18-14)8-7-12-5-3-2-4-6-12/h2-6,10H,7-9,11H2,1H3,(H,17,20).
What are the key properties of 2-bromo-N-[3-(methoxymethyl)-1-(2-phenylethyl)pyrazol-4-yl]acetamide?
2-bromo-N-[3-(methoxymethyl)-1-(2-phenylethyl)pyrazol-4-yl]acetamide has a molecular weight of 352.23 g/mol, XLogP of 2.61, 7 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-bromo-N-[3-(methoxymethyl)-1-(2-phenylethyl)pyrazol-4-yl]acetamide is sourced from PubChem (CID 67198226), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).